Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Biochim Biophys Acta. 2014 Aug 1;1842(11):2174–2183. doi: 10.1016/j.bbadis.2014.07.026

Table 1.

Clinical characteristics and plasma cathepsin G levels in patients with or without coronary heart disease (CHD).*

Variables Non-CHDz
(n = 61)		 SAP
(n = 45)		 UAP
(n = 67)		 AMI
(n = 59)
Age (years) 45 (22, 74) 57 (36, 78)*** 60 (25, 69)*** 62 (29, 79)***
Sex (female/male) 22/39 21/24 32/35 9/50***
Type 2 diabetes mellitus (%) – 8.89 13.43 13.59
Hypertension (%) – 62.22 71.64 50.85
Total cholesterol (mmol/L) 4.22
(5.59, 2.74)		 4.73**
(6.40, 2.56)		 4.89***
(8.46, 2.91)		 4.64**
(7.55, 3.03)
Triglyceride (mmol/L) 1.44
(2.18, 0.50)		 1.74***
(4.66, 0.56)		 1.57
(4.29, 0.37)		 2.03***
(7.90, 0.28)
LDL (mmol/L) 2.47
(3.64, 1.08)		 2.81**
(4.81, 1.82)		 3.02***
(5.43, 1.72)		 2.77**
(5.45, 1.59)
HDL (mmol/L) 1.25
2.07, 0.20)		 1.30
(2.34, 0.68)		 1.18
(2.52, 0.61)		 1.03***
(2.31, 0.35)
Cathepsin G (U/mL) 440.70
(40.00, 1874.70)		 241.90***
(10.45, 1617.70)		 330.00***
(74.05, 2468.00)		 284.90***
(28.60, 1350.45)

AMI, acute myocardial infarction; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SAP, stable angina pectoris; UAP, unstable angina pectoris.

*

Values are expressed as median (minimum, maximum) or a percentage.

**

P < 0.05 compared with the non-CHD group.

***

P < 0.01 compared with the non-CHD group.